Omalizumab

Drug Levels and Effects:




Drug Levels:


Maternal Levels.

Relevant published information was not found as of the revision date.

Infant Levels.

Relevant published information was not found as of the revision date.


Effects in Breastfed Infants:


Relevant published information was not found as of the revision date.


Possible Effects on Lactation:


Relevant published information was not found as of the revision date.


References:






Substance Identification:




Substance Name:

Omalizumab

CAS Registry Number:

242138-07-4

Drug Class:


Anti
  • -Allergic Agents

  • Anti
  • -Asthmatic Agents

  • Antibodies, Monoclonal, Humanized

  • Antibodies,
  • Anti
  • -Idiotypic


  • Administrative Information:




    LactMed Record Number:


    890


    Last Revision Date:


    Disclaimer:Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.